Skip to main content
. Author manuscript; available in PMC: 2019 Aug 30.
Published in final edited form as: Biol Blood Marrow Transplant. 2016 Dec 19;23(3):405–411. doi: 10.1016/j.bbmt.2016.12.624

Figure 2.

Figure 2.

Cumulative incidence curves for nonrelapse mortality (A) and relapse (B), and Kaplan-Meier curve for overall survival (C), according to treatment with placebo, daclizumab 0.3 mg/kg, or daclizumab 1.2 mg/kg.